Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Protein A or G purified from hybridoma culture supernatant
Reconstitute at 0.5 mg/mL in sterile PBS.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for CCL27/CTACK Antibody (124302)
C-C motif chemokine 27
chemokine (C-C motif) ligand 27
CTACKSmall-inducible cytokine A27
cutaneous T-cell attracting chemokine
Cutaneous T-cell-attracting chemokine
IL-11 Ralpha-locus chemokine
ILCCC chemokine ILC
SCYA27IL-11 R-alpha-locus chemokine
small inducible cytokine subfamily A (Cys-Cys), member 27
CCL27, also known as CTACK (cutaneous T cell-attracting chemokine), ALP, ILC, and ESkine, is a member of the CC family of chemokines (1). Mature human CCL27 is an 88 amino acid (aa) protein that shares 57% aa sequence identity with mouse and rat CCL27 (2). It shares 11%‑35% aa sequence identity with other human CC chemokines. An alternately spliced form of mouse CCL27, known as PESKY, is localized to the nucleus and promotes cellular migration (3). CCL27 is constitutively expressed by keratinocytes and is up‑regulated by inflammatory stimuli and in wounded skin (4‑7). CCL27 binds the chemokine receptor CCR10, glycosaminoglycans in the extracellular matrix, sulfated tyrosine residues on PSGL-1, and determinants on the surface of fibroblasts and endothelial cells (5, 7‑9). CCL27 cooperates with CCL17/TARC in inducing the migration of cutaneous lymphocyte antigen (CLA) positive memory T cells to the skin during inflammation (4, 6, 10‑12). Endothelial cell-bound CCL27 can mediate the adhesion of those cells to CLA+ T cells (6). CCL27 also induces the migration of keratinocyte precursors from bone marrow to the skin, thereby promoting wound healing (7). In humans, serum CCL27 levels are elevated and correlate with disease severity in atopic dermatitis, psoriasis vulgaris, and mycosis fungoides (13‑15).
Kunkel, L. and E.C. Butcher (2002) Immunity 16:1.
Ishikawa-Mochizuki, I. et al. (1999) FEBS Lett. 460:544.
Gortz, A. et al. (2002) J. Immunol. 169:1387.
Morales, J. et al. (1999) Proc. Natl. Acad. Sci. 96:14470.
Homey, B. et al. (2000) J. Immunol. 164:3465.
Homey, B. et al. (2002) Nat. Med. 8:157.
Inokuma, D. et al. (2006) Stem Cells 24:2810.
Jarmin, D. et al. (2000) J. Immunol. 164:3460.
Hirata, T. et al. (2004) J. Biol. Chem. 279:51775.
Vestergaard, C. et al. (2004) Exp. Dermatol. 13:551.
Reiss, Y. et al. (2001) J. Exp. Med. 194:1541.
Soler, D. et al. (2003) Blood 101:1677.
Kakinuma, T. et al. (2003) J. Allergy Clin. Immunol. 111:592.
Hijnen, D. et al. (2004) J. Allergy Clin. Immunol. 113:334.
Fujita, Y. et al. (2006) Clin. Cancer Res. 12:2670.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our CCL27/CTACK Antibody (124302) and receive a gift card or discount.